se ha leído el artículo
array:19 [ "pii" => "X0211699502027693" "issn" => "02116995" "estado" => "S300" "fechaPublicacion" => "2002-04-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2002;22 Supl 2:48" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1736 "formatos" => array:3 [ "EPUB" => 194 "HTML" => 1214 "PDF" => 328 ] ] "itemSiguiente" => array:15 [ "pii" => "X0211699502027685" "issn" => "02116995" "estado" => "S300" "fechaPublicacion" => "2002-04-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2002;22 Supl 2:49-51" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3953 "formatos" => array:3 [ "EPUB" => 193 "HTML" => 3277 "PDF" => 483 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Blood presure control in dialysis patients: HD vs CAPD" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "49" "paginaFinal" => "51" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. C. RIELLA" "autores" => array:1 [ 0 => array:1 [ "nombre" => "M. C. RIELLA" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699502027685?idApp=UINPBA000064" "url" => "/02116995/00000022000000S2/v0_201502091327/X0211699502027685/v0_201502091327/en/main.assets" ] "itemAnterior" => array:15 [ "pii" => "X0211699502027708" "issn" => "02116995" "estado" => "S300" "fechaPublicacion" => "2002-04-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2002;22 Supl 2:46-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2974 "formatos" => array:3 [ "EPUB" => 203 "HTML" => 1875 "PDF" => 896 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "The HOPE (Heart Outcomes Prevention in Evaluation) trial" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "46" "paginaFinal" => "47" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "B. H. R. WOLFFENBUTTEL" "autores" => array:1 [ 0 => array:1 [ "nombre" => "B. H. R. WOLFFENBUTTEL" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699502027708?idApp=UINPBA000064" "url" => "/02116995/00000022000000S2/v0_201502091327/X0211699502027708/v0_201502091327/en/main.assets" ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Cardiovascular prevention and blood pressure reduction: an overview of the outcome trials" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "48" ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. A. STAESSEN , J. G. WANG , L. THIJS" "autores" => array:1 [ 0 => array:1 [ "nombre" => "J. A. STAESSEN , J. G. WANG , L. THIJS" ] ] ] ] "textoCompleto" => "NEFROLOGÍA. Vol. XXII. Suplemento 2. 2002 Cardiovascular prevention and blood pressure reduction: an overview of the outcome trials J. A. Staessen, J. G. Wang and L. Thijs Study Coordinating Centre. University of Leuven, B-3000 Leuven. Belgium. In a quantiative overview of published trials, we investigated whether pharmacological properties of antihypertensive drugs or reduction of SBP explain CV outcomes in hypertensive or high-risk patients. We extracted summary statistics from published articles and computed pooled odds ratios for experimental vs reference treatment from stratified 2 x 2 contingency tables after application of Zelen's test of heterogeneity. Using meta-regression, we correlated across trials odds ratios with differences in SBP between study groups. In 9 recent trials, 62 605 hypertensive patients were randomised to initial treatment with older or newer drugs. Compared with diuretics and -blockers, calcium-channel blockers and converting-enzyme inhibitors offered similar overall CV protection, but calcium-channel blockers provided more reduction in the risk of stroke (13.5%, 95% CI 1.3-24.2%, p = 0.03) and less reduction in the risk of MI (19.2%, 95% CI 3.5-37.3%, p = 0.01). Among these 9 trials, there was significant heterogeneity due to the higher risk of CV events on doxazosin in the ALLHAT trial and the higher risk of stroke on captopril in the CAPPP study. However, in these 2 trials, the difference in SBP between the randomised groups was 2-3 mmHg. Similar SBP differences occurred in the NORDIL trial (diltiazem vs older drugs) and in 3 other trials (HOPE, PART2 and SCAT) testing a converting-enzyme inhibitor against placebo in high-risk patients. Metaregression across 27 trials (136 124 patients) showed that the observed odds ratios could be explained in terms of the achieved differences in SBP between study groups except for the NORDIL trial, in which the risk of stroke was lower on diltiazem despite a 3.1 mmHg higher SBP. The finding that in the reviewed trials BP reduction largely accounted for outcome emphasizes the desirability of blood pressure control. On average, all current antihypertensive drugs have similar long-term efficacy and safety. Calciumchannel blockers may be particularly effective in preventing stroke. The hypothesis that convertingenzyme inhibitors or -blockers might influence CV prognosis over and beyond their antihypertensive effect remains unproved. 48 " "pdfFichero" => "P7-E193-S140-A3699.pdf" "tienePdf" => true ] "idiomaDefecto" => "en" "url" => "/02116995/00000022000000S2/v0_201502091327/X0211699502027693/v0_201502091327/en/main.assets" "Apartado" => array:4 [ "identificador" => "35407" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Suplementos" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/02116995/00000022000000S2/v0_201502091327/X0211699502027693/v0_201502091327/en/P7-E193-S140-A3699.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699502027693?idApp=UINPBA000064" ]
Idioma original: Inglés
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 4 | 9 | 13 |
2024 Octubre | 35 | 30 | 65 |
2024 Septiembre | 25 | 22 | 47 |
2024 Agosto | 61 | 53 | 114 |
2024 Julio | 30 | 21 | 51 |
2024 Junio | 34 | 34 | 68 |
2024 Mayo | 66 | 28 | 94 |
2024 Abril | 36 | 22 | 58 |
2024 Marzo | 20 | 19 | 39 |
2024 Febrero | 29 | 36 | 65 |
2024 Enero | 17 | 22 | 39 |
2023 Diciembre | 33 | 19 | 52 |
2023 Noviembre | 19 | 33 | 52 |
2023 Octubre | 22 | 32 | 54 |
2023 Septiembre | 24 | 27 | 51 |
2023 Agosto | 27 | 19 | 46 |
2023 Julio | 23 | 25 | 48 |
2023 Junio | 31 | 19 | 50 |
2023 Mayo | 27 | 29 | 56 |
2023 Abril | 13 | 16 | 29 |
2023 Marzo | 15 | 25 | 40 |
2023 Febrero | 17 | 23 | 40 |
2023 Enero | 22 | 19 | 41 |
2022 Diciembre | 22 | 32 | 54 |
2022 Noviembre | 25 | 28 | 53 |
2022 Octubre | 42 | 49 | 91 |
2022 Septiembre | 24 | 33 | 57 |
2022 Agosto | 28 | 50 | 78 |
2022 Julio | 18 | 37 | 55 |
2022 Junio | 18 | 28 | 46 |
2022 Mayo | 20 | 32 | 52 |
2022 Abril | 28 | 32 | 60 |
2022 Marzo | 22 | 40 | 62 |
2022 Febrero | 24 | 44 | 68 |
2022 Enero | 25 | 39 | 64 |
2021 Diciembre | 19 | 44 | 63 |
2021 Noviembre | 24 | 34 | 58 |
2021 Octubre | 29 | 34 | 63 |
2021 Septiembre | 20 | 32 | 52 |
2021 Agosto | 22 | 29 | 51 |
2021 Julio | 18 | 28 | 46 |
2021 Junio | 14 | 10 | 24 |
2021 Mayo | 17 | 20 | 37 |
2021 Abril | 20 | 18 | 38 |
2021 Marzo | 23 | 10 | 33 |
2021 Febrero | 33 | 7 | 40 |
2021 Enero | 12 | 18 | 30 |
2020 Diciembre | 11 | 12 | 23 |
2020 Noviembre | 10 | 6 | 16 |
2020 Octubre | 8 | 7 | 15 |
2020 Septiembre | 8 | 9 | 17 |
2020 Agosto | 18 | 11 | 29 |
2020 Julio | 22 | 13 | 35 |
2020 Junio | 16 | 11 | 27 |
2020 Mayo | 10 | 18 | 28 |
2020 Abril | 23 | 10 | 33 |
2020 Marzo | 10 | 17 | 27 |
2020 Febrero | 22 | 9 | 31 |
2020 Enero | 25 | 18 | 43 |
2019 Diciembre | 12 | 15 | 27 |
2019 Noviembre | 16 | 7 | 23 |
2019 Octubre | 3 | 4 | 7 |
2019 Septiembre | 15 | 10 | 25 |
2019 Agosto | 8 | 8 | 16 |
2019 Julio | 14 | 14 | 28 |
2019 Junio | 16 | 3 | 19 |
2019 Mayo | 12 | 7 | 19 |
2019 Abril | 38 | 26 | 64 |
2019 Marzo | 15 | 12 | 27 |
2019 Febrero | 6 | 10 | 16 |
2019 Enero | 9 | 11 | 20 |
2018 Diciembre | 20 | 20 | 40 |
2018 Noviembre | 48 | 6 | 54 |
2018 Octubre | 31 | 9 | 40 |
2018 Septiembre | 23 | 6 | 29 |
2018 Agosto | 11 | 8 | 19 |
2018 Julio | 14 | 6 | 20 |
2018 Junio | 12 | 9 | 21 |
2018 Mayo | 14 | 10 | 24 |
2018 Abril | 13 | 4 | 17 |
2018 Marzo | 12 | 7 | 19 |
2018 Febrero | 10 | 2 | 12 |
2018 Enero | 10 | 5 | 15 |
2017 Diciembre | 13 | 3 | 16 |
2017 Noviembre | 9 | 6 | 15 |
2017 Octubre | 10 | 3 | 13 |
2017 Septiembre | 5 | 3 | 8 |
2017 Agosto | 14 | 5 | 19 |
2017 Julio | 12 | 7 | 19 |
2017 Junio | 13 | 13 | 26 |
2017 Mayo | 10 | 5 | 15 |
2017 Abril | 4 | 2 | 6 |
2017 Marzo | 8 | 7 | 15 |
2017 Febrero | 13 | 3 | 16 |
2017 Enero | 10 | 3 | 13 |
2016 Diciembre | 15 | 7 | 22 |
2016 Noviembre | 19 | 7 | 26 |
2016 Octubre | 23 | 6 | 29 |
2016 Septiembre | 21 | 5 | 26 |
2016 Agosto | 53 | 1 | 54 |
2016 Julio | 62 | 0 | 62 |
2016 Junio | 49 | 0 | 49 |
2016 Mayo | 76 | 0 | 76 |
2016 Abril | 33 | 0 | 33 |
2016 Marzo | 33 | 0 | 33 |
2016 Febrero | 46 | 0 | 46 |
2016 Enero | 35 | 0 | 35 |
2015 Diciembre | 43 | 0 | 43 |
2015 Noviembre | 36 | 0 | 36 |
2015 Octubre | 27 | 0 | 27 |
2015 Septiembre | 35 | 0 | 35 |
2015 Agosto | 21 | 0 | 21 |
2015 Julio | 28 | 0 | 28 |
2015 Junio | 10 | 0 | 10 |
2015 Mayo | 13 | 0 | 13 |